VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,031 | -18.9% | 25,933 | +23.7% | 0.00% | – |
| Q2 2023 | $138,100 | +2.8% | 20,956 | +6.0% | 0.00% | – |
| Q1 2023 | $134,279 | +1.8% | 19,776 | +10.8% | 0.00% | – |
| Q4 2022 | $131,867 | +18.8% | 17,844 | +59.2% | 0.00% | – |
| Q3 2022 | $111,000 | +0.9% | 11,210 | +11.4% | 0.00% | – |
| Q2 2022 | $110,000 | -34.5% | 10,064 | -5.9% | 0.00% | – |
| Q4 2021 | $168,000 | -12.5% | 10,698 | -8.4% | 0.00% | – |
| Q4 2019 | $192,000 | +34.3% | 11,685 | +8.2% | 0.00% | – |
| Q3 2019 | $143,000 | -2.1% | 10,796 | +4.3% | 0.00% | – |
| Q2 2019 | $146,000 | -21.9% | 10,352 | +1.6% | 0.00% | – |
| Q1 2019 | $187,000 | – | 10,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |